Jamieson Wellness (TSE:JWEL – Get Free Report) was downgraded by investment analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Friday,BayStreet.CA reports. They presently have a C$45.75 price target on the stock, up from their previous price target of C$45.00. Stifel Nicolaus’ price objective would suggest a potential upside of 0.28% from the company’s current price.
Separately, Canadian Imperial Bank of Commerce downgraded shares of Jamieson Wellness from an “outperformer” rating to a “tender” rating and increased their price objective for the company from C$44.00 to C$45.75 in a research report on Friday. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of C$45.30.
Check Out Our Latest Stock Analysis on Jamieson Wellness
Jamieson Wellness Stock Up 9.9%
Jamieson Wellness (TSE:JWEL – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.46 EPS for the quarter. Jamieson Wellness had a return on equity of 15.25% and a net margin of 8.71%.The firm had revenue of C$233.84 million for the quarter. Research analysts anticipate that Jamieson Wellness will post 2.1438892 earnings per share for the current year.
Jamieson Wellness Company Profile
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.
See Also
- Five stocks we like better than Jamieson Wellness
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
